Tag Archives: U.S.

Denver votes to become first U.S. city to decriminalize ‘magic mushrooms’

Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA/Handout via REUTERS (Reuters) – Denver will become the first city in the United States to decriminalize magic mushrooms, based on final unofficial results on Wednesday of a ballot initiative about… Read More »

U.S. high court temporarily blocks Louisiana abortion restrictions

WASHINGTON (Reuters) – The U.S. Supreme Court on Friday temporarily prevented a Louisiana law imposing strict regulations on abortion clinics from taking effect in a case that presents a key test on the contentious issue following last year’s retirement of Justice Anthony Kennedy, a pivotal supporter of abortion rights. FILE PHOTO: Anti-abortion marchers rally at… Read More »

U.S. citizen leaks data on 14,200 people in Singapore with HIV

SINGAPORE (Reuters) – An HIV-positive American who had been deported from Singapore after serving a jail term has leaked online the personal data of 14,200 Singaporeans and foreigners diagnosed in the city-state with the virus. A view of the skyline of Singapore October 16, 2018. REUTERS/Edgar Su The disclosure by Singapore’s health ministry late Monday,… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »